We are live on ! Find out more
VA

Vident Advisory Portfolio holdings

AUM $11.7B
1-Year Est. Return 37.32%
This Fund
S&P 500
This Quarter Est. Return
+4.06%
1 Year Est. Return
+37.32%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$3.62B
AUM Growth
-$1.18B
Cap. Flow
-$1.18B
Cap. Flow %
-32.7%
Top 10 Hldgs %
16.49%
Holding
1,533
New
211
Increased
794
Reduced
387
Closed
126

Top Sells

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$52.4M
2
JNJ icon
Johnson & Johnson
JNJ
+$39.1M
3
TMUS icon
T-Mobile US
TMUS
+$37.2M
4
ABBV icon
AbbVie
ABBV
+$35.8M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$34.6M

Sector Composition

Rank Sector Weight
1 Technology 29.28%
2 Financials 10.77%
3 Consumer Discretionary 8.99%
4 Industrials 8.73%
5 Healthcare 6.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BCO icon
676
Brink's
BCO
$5.02B
$800K 0.02%
+7,815
New +$745K
OXY icon
677
Occidental Petroleum
OXY
$57B
$800K 0.02%
12,691
+1,053
+9% +$67.5K
THO icon
678
Thor Industries
THO
$3.99B
$799K 0.02%
8,553
+3,814
+80% +$381K
VVX icon
679
V2X
VVX
$2.62B
$796K 0.02%
+16,600
New +$786K
EXTR icon
680
Extreme Networks
EXTR
$3.86B
$794K 0.02%
59,055
+23,723
+67% +$273K
UAL icon
681
United Airlines
UAL
$38.4B
$791K 0.02%
16,259
-5,037
-24% -$254K
GPOR icon
682
Gulfport Energy Corp
GPOR
$2.83B
$791K 0.02%
+5,236
New +$821K
ERIC icon
683
Ericsson
ERIC
$30.7B
$789K 0.02%
127,820
+89,873
+237% +$502K
SWBI icon
684
Smith & Wesson
SWBI
$655M
$789K 0.02%
+54,989
New +$903K
USDU icon
685
WisdomTree Bloomberg US Dollar Bullish Fund
USDU
$472M
$788K 0.02%
29,093
-130,062
-82% -$3.46M
TROW icon
686
T. Rowe Price
TROW
$25B
$782K 0.02%
6,783
+1,563
+30% +$180K
CCI icon
687
Crown Castle
CCI
$32.7B
$781K 0.02%
7,989
-1,374
-15% -$135K
MGY icon
688
Magnolia Oil & Gas
MGY
$5.83B
$779K 0.02%
30,753
+16,454
+115% +$420K
SCHO icon
689
Schwab Short-Term US Treasury ETF
SCHO
$12.7B
$778K 0.02%
+32,346
New +$776K
BGDE
690
Big Digital Energy Inc
BGDE
$29.8M
$775K 0.02%
27,085
+5,097
+23% +$131K
CMBT
691
CMB.TECH NV
CMBT
$4.57B
$772K 0.02%
46,701
+11,200
+32% +$190K
FMX icon
692
Fomento Económico Mexicano
FMX
$43.3B
$772K 0.02%
7,173
+1,672
+30% +$196K
MOS icon
693
The Mosaic Company
MOS
$7.09B
$771K 0.02%
26,692
+10,160
+61% +$306K
EXPD icon
694
Expeditors International
EXPD
$22.9B
$768K 0.02%
6,158
-534
-8% -$63.6K
KFRC icon
695
Kforce
KFRC
$983M
$768K 0.02%
12,363
+478
+4% +$30.4K
TMHC icon
696
Taylor Morrison
TMHC
$763K 0.02%
13,754
+7,601
+124% +$434K
MOMO
697
Hello Group
MOMO
$869M
$762K 0.02%
124,487
-14,474
-10% -$84.5K
CRSP icon
698
CRISPR Therapeutics
CRSP
$4.58B
$762K 0.02%
14,104
+61
+0.4% +$3.53K
TEVA icon
699
Teva Pharmaceuticals
TEVA
$35.9B
$757K 0.02%
+46,557
New +$717K
IEX icon
700
IDEX
IEX
$16.5B
$754K 0.02%
3,749
+1,822
+95% +$398K

Similar funds

Vident Advisory's Q2 2024 Portfolio in Review

As of Q2 2024, Vident Advisory held 1,533 positions worth $3.62B, down 25% from $4.8B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Vident Advisory withdrew a net $1.18B in Q2 2024, closing 126 positions and reducing 387 holdings. Its most notable exit was Enterprise Products Partners, an estimated $20M position sold in full.

By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 23% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, Vident Advisory opened a new position in Vanguard Intermediate-Term Treasury ETF worth $19M.

  • Vident Advisory's largest Q2 2024 buy was Vanguard Intermediate-Term Treasury ETF: 326,646 shares worth $19M.
  • Vident Advisory added most to Tesla in Q2 2024, an estimated $29.1M increase.
  • Vident Advisory's biggest Q2 2024 reduction was UnitedHealth, cutting an estimated $52.4M.
  • Vident Advisory fully exited Enterprise Products Partners in Q2 2024, selling an estimated $20M.
  • Vident Advisory's ten largest holdings make up 16% of its $3.62B portfolio in Q2 2024.
  • Vident Advisory opened 211 new positions and closed 126 in Q2 2024.
  • Vident Advisory's portfolio value fell 25% quarter-over-quarter to $3.62B.

Based on Vident Advisory's 13F filing for Q2 2024, filed 14 Aug 2024.